Hu et al. (82) demonstrated that polysaccharides isolated from the mycelium of H. erinaceus exhibited anti-AD activity; treatment with these polysaccharides significantly improved cognitive behaviors in AD mice while alleviating brain damage, reducing amyloid deposition, mitigating tau hyperphosphorylation, and decreasing oxidative stress within the brain. Here, MAPT is linked to Alzheimer disease.